PGCM
VCYT icon

Prescott Group Capital Management’s Veracyte VCYT Stock Holding History

Prescott Group Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-37,000
Closed -$465K – 191
2018
Q4 		$465K Buy
+37,000
New +$438K 0.09% 169

Other funds holding VCYT

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prescott Group Capital Management's VCYT Position: Q1 2019 in Review

Prescott Group Capital Management sold out of Veracyte (VCYT) in Q1 2019, closing a stake of 37,000 shares — an estimated $465K sold.

Prescott Group Capital Management first reported a position in VCYT in Q4 2018 and held it in 1 quarter. The position peaked at $465K in Q4 2018. 149 funds tracked by Wall St. Rank hold VCYT as of Q1 2019.

  • Prescott Group Capital Management reported no remaining Veracyte position as of Q1 2019 after selling out during the quarter.
  • Prescott Group Capital Management sold 37,000 Veracyte shares in Q1 2019, an estimated $465K.
  • Prescott Group Capital Management first reported a position in Veracyte in Q4 2018 and held it in 1 quarter.
  • Prescott Group Capital Management's Veracyte position peaked at $465K in Q4 2018.
  • 149 funds tracked by Wall St. Rank held Veracyte as of Q1 2019.

Based on Prescott Group Capital Management's 13F filing for Q1 2019, filed 10 May 2019.